CG Oncology’s late-stage bladder cancer treatment notched a complete response in roughly three-quarters of treated patients, fueling optimism that the company’s Wall Street success story is no fluke.

Return on Assets (ROA): CG Oncology's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -6.12%, the company may face hurdles in generating ...

The Carlyle Group Inc. (NASDAQ:CG) is one of the dirt cheap stocks to buy now. On February 26, Reuters reported that Carlyle Group announced an ambitious goal to raise $200 billion in new capital by ...

In a move that will be seized on as a sign that the IPO window is reopening in 2023, CG Oncology has not only become the first biotech to go public this year but overshot its own estimates. The ...

CHICAGO & SAN DIEGO--(BUSINESS WIRE)--CG Life, an integrated digital marketing and communications agency specializing in life science and healthcare, today announced David Ormesher as chief executive ...

Communications firm CG Life rolled out a brand refresh Wednesday morning to highlight its commitment to science. The Shaped by Science rebrand seeks to underscore the inspiration behind the agency’s ...

When it comes to golf club technology, the term “center of gravity” — “CG” or “CoG” for short — gets thrown around quite a bit, but it isn’t often explained to the average golf consumer. While CG may ...